Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology Franchise

September 17, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search